Efficacy of a 1:1 ratio VWF/FVIII concentrate in patients with von Willebrand disease.

MLA

Kuppens, Geoffrey Z. L., et al. “Efficacy of a 1:1 Ratio VWF/FVIII Concentrate in Patients with von Willebrand Disease.” Haemophilia, vol. 30, no. 5, Sept. 2024, pp. 1148–54. EBSCOhost, https://doi.org/10.1111/hae.15079.

APA

Kuppens, G. Z. L., Fischer, K., van Galen, K. P. M., van Beers, E. J., Van der Valk, P. R., Kremer Hovinga, I. C. L., van Vulpen, L. F. D., & Schutgens, R. E. G. (2024). Efficacy of a 1:1 ratio VWF/FVIII concentrate in patients with von Willebrand disease. Haemophilia, 30(5), 1148–1154. https://doi.org/10.1111/hae.15079

Chicago

Kuppens, Geoffrey Z. L., Kathelijn Fischer, Karin P. M. van Galen, Eduard J. van Beers, Paul R. Van der Valk, Idske C. L. Kremer Hovinga, Lize F. D. van Vulpen, and Roger E. G. Schutgens. 2024. “Efficacy of a 1:1 Ratio VWF/FVIII Concentrate in Patients with von Willebrand Disease.” Haemophilia 30 (5): 1148–54. doi:10.1111/hae.15079.